#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Astrocytoma Infantile spasms Osteomyelitis Neuropathic arthropathy Hyperinsulinaemic hypoglycaemia Congenital megacolon Autoimmune myositis Extra-osseous Ewing's sarcoma Arterial tortuosity syndrome Ventricular tachycardia Mucopolysaccharidosis I Acute graft versus host disease Polycythaemia vera Malignant melanoma Transplant rejection More trials…

    Learn about Rare Diseases

    SAPHO syndrome – Life with Disease Paraneoplastic neurological syndrome – Basic Information Arterial tortuosity syndrome – Trials in Disease Glomerulonephritis rapidly progressive – Basic Information Testicular leiomyosarcoma – Basic Information Gaucher’s disease type I – Basic Information Medulloblastoma recurrent – Trials in Disease Systemic sclerosis pulmonary – Treatment Idiopathic inflammatory myopathy – Treatment Cytokine release syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Immunoglobulin G Immunoglobulin A LUMC-BOB1-B7-TCR.1 Allogeneic Faecal Microbiota Bilastine Bexmarilimab Mva-Hbvac Prednisolone Fremanezumab SEVUPARIN Betula Pendula Pollen Extract Olanzapine Baclofen Odm-208 Adct-402 TETANUS TOXOID ZILEBESIRAN Dopamine Hydrochloride Eribulin Isis 678354 Sodium Salt More therapies…

    Learn about Your Condition

    Body mass index increased Sexual dysfunction Pseudoxanthoma elasticum Follicular lymphoma stage II Fibrosarcoma metastatic Hepatic cirrhosis Von Hippel-Lindau disease Vulvovaginal dryness Laryngeal cancer stage I Streptococcal infection Pancoast's tumour Type 1 diabetes mellitus Neuroendocrine carcinoma Ewing's sarcoma recurrent Bladder cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Universitaire De La Reunion

Centre Hospitalier Universitaire De La Reunion

Allee Des Topazes, Cs 11021, St Denis, 97400, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Cabozantinib and Drug Combination for Untreated Metastatic Renal Cell Carcinoma in Intermediate and Poor Risk Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal cell carcinoma
    Investigated Drugs:
    • Axitinib
    • Cabozantinib
    • Ipilimumab
    Austria Belgium Czechia Denmark Finland France +5

  • Study Comparing Vincristine, Actinomycin-D, and Doxorubicin with Vincristine, Carboplatin, and Etoposide for Stage IV Childhood Kidney Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephroblastoma
    Investigated Drugs:
    • Dactinomycin
    • Carboplatin
    • Doxorubicin Hydrochloride
    Austria Belgium Czechia Denmark France Germany +5

  • Study on Darolutamide and Triptorelin for Patients with Localized High-Risk Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Triptorelin
    • Darolutamide
    France Spain

  • Study on Metronomic Chemotherapy for Children and Teenagers with Relapsed or Refractory Wilms Tumor Using Vincristine, Irinotecan, Etoposide, Temozolomide, and Isotretinoin

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Nephroblastoma
    Investigated Drugs:
    • Isotretinoin
    • Temozolomide
    • Etoposide
    France

  • Study on Retinoblastoma Treatment: Evaluating the Effectiveness of Topotecan, Vincristine Sulfate, and Etoposide in Patients Eligible for Conservative Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinoblastoma
    Investigated Drugs:
    • Melphalan Hydrochloride
    • Carboplatin
    • Etoposide
    France

  • Study on the Effects of Methylprednisolone in Infants with Neuroendocrine Cell Hyperplasia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neuroendocrine cell hyperplasia of infancy
    Investigated Drugs:
    • Methylprednisolone Hydrogen Succinate
    • Lidocaine Hydrochloride Monohydrate
    • Methylprednisolone
    France

  • Study on Mifamurtide with Chemotherapy for Patients with High-Risk Osteosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteosarcoma metastatic
    • Osteosarcoma
    Investigated Drugs:
    • Mifamurtide
    • Ifosfamide
    • Cisplatin
    France

  • Study on Vinblastine for Children and Adolescents with Standard Risk ALK-Positive Anaplastic Large Cell Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Anaplastic large cell lymphoma T- and null-cell types
    Investigated Drugs:
    • Vinblastine Sulfate
    Austria Belgium Denmark Finland France Germany +2

  • Study on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Methylprednisolone Hemisuccinate
    • Brentuximab Vedotin
    • Cyclophosphamide Monohydrate
    Belgium France

  • Study on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • 2,4,6,7,8,9-Hexahydro-4-((2-Methylphenyl)Methyl)-7-(Phenylmethyl)Imidazo(1,2-A)Pyrido(3,4-E)Pyrimidin-5(1H)-One
    • Everolimus
    Austria Belgium Czechia Denmark Finland France +5
Previous Page
1 2 3 4 5 … 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!